Correlations of placental perfusion and PlGF protein expression in early human pregnancy

American Journal of Obstetrics and Gynecology

Volumn 194, Issue 6, 2006, Pages 1625-1629

  Welch, Paul C ^a   Amankwah, Kofi S ^a   Miller, Patience ^a   McAsey, Mary E ^a   Torry, Donald S ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood flow velocity; Doppler ultrasound; Placenta growth factor; Pregnancy

Indexed keywords

PLACENTAL GROWTH FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER FLOWMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATION PERIOD; HUMAN; PLACENTA PERFUSION; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTOLE; UMBILICAL ARTERY;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; HUMANS; PLACENTA; PREGNANCY; PREGNANCY PROTEINS; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; REGIONAL BLOOD FLOW; RHEOLOGY; ULTRASONOGRAPHY, DOPPLER; UMBILICAL ARTERIES;

EID: 33646771324     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2006.01.012     Document Type: Article

References (30)

1. Torry D.S., Hinrichs M., and Torry R.J. Determinants of placental vascularity. Am J Reprod Immunol 51 (2004) 257-268
2. Wulff C., Weigand M., Kreienberg R., and Fraser H.M. Angiogenesis during primate placentation in health and disease. Reproduction 126 (2003) 569-577
3. Reynolds L.P., and Redmer D.A. Angiogenesis in the placenta. Biol Reprod 64 (2001) 1033-1040
4. Ahmed A., and Perkins J. Angiogenesis and intrauterine growth restriction. Baillieres Best Pract Res Clin Obstet Gynaecol 14 (2000) 981-998
5. Iyer S., Leonidas D.D., Swaminathan G.J., Maglione D., Battisti M., Tucci M., et al. The crystal structure of human placenta growth factor-1 (PlGF-1), an angiogenic protein, at 2.0 A resolution. J Biol Chem 276 (2001) 12153-12161
6. Cao Y., Ji W.R., Qi P., and Rosin A. Placenta growth factor: identification and characterization of a novel isoform generated by RNA alternative splicing. Biochem Biophys Res Commun 235 (1997) 493-498
7. Maglione D., Guerriero V., Viglietto G., Delli-Bovi P., and Persico M.G. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci U S A 88 (1991) 9267-9271
8. Zhou Y., McMaster M., Woo K., Janatpour M., Perry J., Karpanen T., et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol 160 (2002) 1405-1423
9. Khaliq A., Li X.F., Shams M., Sisi P., Acevedo C.A., Whittle M.J., et al. Localisation of placenta growth factor (PIGF) in human term placenta. Growth Factors 13 (1996) 243-250
10. Takahashi A., Sasaki H., Kim S.J., Tobisu K., Kakizoe T., Tsukamoto T., et al. Markedly increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res 54 (1994) 4233-4237
11. Failla C.M., Odorisio T., Cianfarani F., Schietroma C., Puddu P., and Zambruno G. Placenta growth factor is induced in human keratinocytes during wound healing. J Invest Dermatol 115 (2000) 388-395
12. Torry D.S., Wang H.S., Wang T.H., Caudle M.R., and Torry R.J. Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol 179 (1998) 1539-1544
13. Tidwell S.C., Ho H.N., Chiu W.H., Torry R.J., and Torry D.S. Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. Am J Obstet Gynecol 184 (2001) 1267-1272
14. Granger J.P., Alexander B.T., Llinas M.T., Bennett W.A., and Khalil R.A. Pathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunction. Microcirculation 9 (2002) 147-160
15. Kingdom J.C., and Kaufmann P. Oxygen and placental vascular development. Adv Exp Med Biol 474 (1999) 259-275
16. Taylor R.N., Grimwood J., Taylor R.S., McMaster M.T., Fisher S.J., and North R.A. Longitudinal serum concentrations of placental growth factor: Evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 188 (2003) 177-182
17. Tjoa M.L., van Vugt J.M., Mulders M.A., Schutgens R.B., Oudejans C.B., and van Wijk I.J. Plasma placenta growth factor levels in mid trimester pregnancies. Obstet Gynecol 98 (2001) 600-607
18. Shibata E., Rajakumar A., Powers R.W., Larkin R.W., Gilmour C., Bodnar L.M., et al. Soluble fms-like tyrosine kinase 1 (sFlt-1) is increased in preeclampsia but not in normotensive pregnancies with small for gestational age neonates: relationship to circulating placental growth factor (PlGF). J Clin Endocrinol Metab (EPub ahead of print) (2005)
19. Szukiewicz D., Szewczyk G., Watroba M., Kurowska E., and Maslinski S. Isolated placental vessel response to vascular endothelial growth factor and placenta growth factor in normal and growth-restricted pregnancy. Gynecol Obstet Invest 59 (2004) 102-107
20. Maynard S.E., Min J.Y., Merchan J., Lim K.H., Li J., Mondal S., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111 (2003) 649-658
21. Levine R.J., Thadhani R., Qian C., Lam C., Lim K.H., Yu K.F., et al. Urinary placental growth factor and risk of preeclampsia. JAMA 293 (2005) 77-85
22. Levine R.J., Maynard S.E., Qian C., Lim K.H., England L.J., Yu K.F., et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350 (2004) 672-683
23. Shore V.H., Wang T.H., Wang C.L., Torry R.J., Caudle M.R., and Torry D.S. Vascular endothelial growth factor, placenta growth factor and their receptors in isolated human trophoblast. Placenta 18 (1997) 657-665
24. Ahmed A., Dunk C., Ahmad S., and Khaliq A. Regulation of placental vascular endothelial growth factor (VEGF) and placenta growth factor (PlGF) and soluble Flt-1 by oxygen: a review. Placenta 21 (2000) S16-S24
25. Khaliq A., Dunk C., Jiang J., Shams M., Li X.F., Acevedo C., et al. Hypoxia down-regulates placenta growth factor, whereas fetal growth restriction up-regulates placenta growth factor expression: molecular evidence for "placental hyperoxia" in intrauterine growth restriction. Lab Invest 79 (1999) 151-170
26. Carmeliet P., Moons L., Luttun A., Vincenti V., Compernolle V., De Mol M., et al. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7 (2001) 575-583
27. Nomura M., Yamagishi S., Harada S., Yamashima T., Yamashita J., and Yamamoto H. Placenta growth factor (PlGF) mRNA expression in brain tumors. J Neurooncol 40 (1998) 123-130
28. Kelly B.D., Hackett S.F., Hirota K., Oshima Y., Cai Z., Berg-Dixon S., et al. Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1. Circ Res 93 (2003) 1074-1081
29. Nagamatsu T., Fujii T., Kusumi M., Zou L., Yamashita T., Osuga Y., et al. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology 145 (2004) 4838-4845
30. Genbacev O., and Miller R.K. Post-implantation differentiation and proliferation of cytotrophoblast cells: in vitro models: a review. Placenta 21 suppl (2000) S45-S49